Zhou ZG - Search Results

1

EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma.

Xiao G, Jin LL, Liu CQ, Wang YC, Meng YM, Zhou ZG, Chen J, Yu XJ, Zhang YJ, Xu J, Zheng L. Xiao G, et al. Among authors: zhou zg. J Immunother Cancer. 2019 Nov 14;7(1):300. doi: 10.1186/s40425-019-0784-9. J Immunother Cancer. 2019. PMID: 31727135 Free PMC article.

2

Antiviral therapy in the improvement of survival of patients with hepatitis B virus-related hepatocellular carcinoma treated with sorafenib.

Xu L, Gao H, Huang J, Wang H, Zhou Z, Zhang Y, Li S, Chen M. Xu L, et al. J Gastroenterol Hepatol. 2015 Jun;30(6):1032-9. doi: 10.1111/jgh.12910. J Gastroenterol Hepatol. 2015. PMID: 25639513

3

Impact of oral anti-hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization.

Zhou ZG, Zheng XR, Zhou Q, Shi M, Zhang YJ, Guo RP, Yuan YF, Chen MS, Lin XJ, Lao XM, Li SP. Zhou ZG, et al. Among authors: zhou q. Chin J Cancer. 2015 May 14;34(5):205-16. doi: 10.1186/s40880-015-0017-7. Chin J Cancer. 2015. PMID: 26058595 Free PMC article.

4

TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma.

Zhou DS, Wang HB, Zhou ZG, Zhang YJ, Zhong Q, Xu L, Huang YH, Yeung SC, Chen MS, Zeng MS. Zhou DS, et al. Among authors: zhou zg. Oncotarget. 2015 Sep 15;6(27):24163-77. doi: 10.18632/oncotarget.4643. Oncotarget. 2015. PMID: 26219398 Free PMC article.

5

A monocyte/granulocyte to lymphocyte ratio predicts survival in patients with hepatocellular carcinoma.

Zhou D, Zhang Y, Xu L, Zhou Z, Huang J, Chen M. Zhou D, et al. Sci Rep. 2015 Oct 21;5:15263. doi: 10.1038/srep15263. Sci Rep. 2015. PMID: 26486016 Free PMC article.

6

A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma.

Jiang SS, Tang Y, Zhang YJ, Weng DS, Zhou ZG, Pan K, Pan QZ, Wang QJ, Liu Q, He J, Zhao JJ, Li J, Chen MS, Chang AE, Li Q, Xia JC. Jiang SS, et al. Among authors: zhou zg. Oncotarget. 2015 Dec 1;6(38):41339-49. doi: 10.18632/oncotarget.5463. Oncotarget. 2015. PMID: 26515587 Free PMC article. Clinical Trial.

7

Expression of Pim-3 in colorectal cancer and its relationship with prognosis.

Zhou Z, Zhang R, Wang R, Zhang Y, Xu L, Chen J, Zhang J, Huang Z, Chen M, Pan Z. Zhou Z, et al. Tumour Biol. 2016 Jul;37(7):9151-6. doi: 10.1007/s13277-016-4806-7. Epub 2016 Jan 14. Tumour Biol. 2016. PMID: 26768612

8

Prospective, single-center cohort study analyzing the efficacy of complete laparoscopic resection on recurrent hepatocellular carcinoma.

Zhang J, Zhou ZG, Huang ZX, Yang KL, Chen JC, Chen JB, Xu L, Chen MS, Zhang YJ. Zhang J, et al. Among authors: zhou zg. Chin J Cancer. 2016 Mar 8;35:25. doi: 10.1186/s40880-016-0088-0. Chin J Cancer. 2016. PMID: 26956022 Free PMC article.

9

Parecoxib prevents complications in hepatocellular carcinoma patients receiving hepatic transarterial chemoembolization: a prospective score-matched cohort study.

Zhou ZG, Chen JB, Qiu HB, Wang RJ, Chen JC, Xu L, Chen MS, Zhang YJ. Zhou ZG, et al. Oncotarget. 2016 May 10;7(19):27938-45. doi: 10.18632/oncotarget.8560. Oncotarget. 2016. PMID: 27056892 Free PMC article.

10

Derived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolization.

Zhou D, Liang J, Xu LI, He F, Zhou Z, Zhang Y, Chen M. Zhou D, et al. Oncol Lett. 2016 May;11(5):2987-2994. doi: 10.3892/ol.2016.4359. Epub 2016 Mar 21. Oncol Lett. 2016. PMID: 27123051 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

594 results

Search Page